EZH2 p.Y646F
About
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | EZH2 p.Y646F | Follicular Lymphoma | Tazemetostat |
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | EZH2 p.Y646F | Follicular Lymphoma | Tazemetostat |